Skip to main content
Equibles

IMMNOV · Immunovia AB (publ)

Use IMMNOV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IMMNOV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
0.0760 SEK -0.0090 (-10.59%) At close · Oct 2
Rebalance outlook locked
Market Cap
92.42M SEK
Shares
672.67M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close0.0760 SEK Open0.0861 SEK Day0.0720–0.0879 SEK 52W close0.0760–0.4025 SEK Avg vol 30d4.9M Last earningsFeb 10, 2027 DataJan 2020–Oct 2026

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 0.0760 SEK Now 0.0760 SEK · 0% Range high 0.4025 SEK
vs 200-day avg -59% vs 50-day avg -49%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XSTO:IMMNOV -45.6% -41.4% -64.7% -18.3% -66.5%

Exchange listing

Market
XSTO
Ticker
IMMNOV
ISIN
SE0006091997
Security
—
Trading currency
SEK

Company

Website
http://immunovia.com/
Investor relations
https://investor.immunovia.com/en/

Other listings of this company

No other verified listings are available.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

DateEventType
2026-11-04 00:00 UTC Interim report Q3 Results publication
2027-02-10 00:00 UTC Year-end report 2026 Results publication

Earnings calls

  • Earnings call · Q4 2026 2027-02-10 Scheduled
    Year-end report 2026
  • Earnings call · Q3 2026 2026-11-04 Scheduled
    Interim report Q3
  • Earnings call · Q2 2026 2026-08-06
    Interim report Q2
  • Earnings call · Q1 2026 2026-05-07
    Interim report Q1
  • Earnings call · Q4 2025 2026-02-24
    Year-end report 2025